Back to Top Skip to main content Skip to sub-navigation

Navy unit provided COVID-19 support to Peruvian First Responders

Fireman getting COVID test in firehouse garage Bombero physician collects sample for testing at the Bellavista Fire Station No. 60 in Callao, Peru. (Courtesy Photo.)

Recommended Content:

Coronavirus | Global Health Engagement | Coronavirus and the COVID-19 Vaccine

U.S. Naval Medical Research Unit Number 6 (NAMRU-6) recently provided COVID-19 support to the Bellavista Fire Station No. 60 in Callao, Peru.

Responding to a reported COVID-19 exposure among the Bellavista Fire Station No. 60 firefighters, NAMRU-6 tested 45 de-identified, coded samples from firefighters with a possible exposure to individuals with confirmed cases SARS-CoV-2, the virus responsible for COVID-19 infection.

The testing performed by NAMRU-6 is based upon the detection of the virus’ nucleic acids through a sensitive method known as Real Time Reverse Transcriptase- Polymerase Chain Reaction. Results identified samples that showed detectable levels of the virus and were provided to fire station leadership the same day. Collaborating with the fire station medical and safety staff allowed immediate isolation of infected individuals to prevent further COVID-19 spread among emergency workers. 

The province of Callao has the second highest number of COVID-19 cases in Peru, and the implementation of infection control measures remains a critical component to slowing the spread of the virus. Through the foresight of the Bellavista Fire Station leadership and the swift response of NAMRU-6 scientists, Bellavista Fire Station No. 60 could continue their critical mission, which includes providing first responder support to the U.S. Navy lab.

The Bellavista Fire Station No. 60 is located on the Centro Médico Naval installation in Callao, which is where the NAMRU-6 compound is also located. The fire station has been supporting the lab dating back to 2009 when NAMRU-6 leadership identified gaps in emergency management response and annual exercises. NAMRU-6 requested firefighting and rescue response support from the fire station and the relationship became official in the NAMRU-6 Emergency Management Plan. The partnership currently supports annual exercises in emergency scenarios such as fire in a laboratory, large-scale chemical spills, large-scale biological spills, rescue of injured personnel, and health emergencies such as a heart attack. 

“The ability to provide a critical service to our Peruvian partners underscores the collaborative effort that NAMRU-6 seeks with all our partners, especially during this unprecedented global crisis,” said U.S. Navy Cmdr. Michael Prouty, deputy research science director at NAMRU-6.

NAMRU-6 Safety Director Roberto Cosio mentioned, “The firemen participate as first responders and provide basic life support or initial emergency aid to injured people. The molecular testing provided to the firemen not only helped prevent the spread of COVID-19 to their coworkers and families, but also the individuals they assist on a daily basis.”

The Peruvian Navy hosts NAMRU-6 at their flagship hospital in Lima, and naval clinics in Iquitos and Puerto Maldonado. NAMRU-6 conducts research on and surveillance of a wide range of infectious diseases of military and public health significance in the region; and anti-microbial resistance monitoring.

“As the host of NAMRU-6 for the past 37 years, the Peruvians have provided us with immeasurable support in advancing our infectious disease research mission,” said U.S. Navy Capt. William Howard, NAMRU-6 commanding officer. “When we received the request from the Bellavista Firefighters, we were more than happy to be able to help with the testing and continue our longstanding friendship.”

You also may be interested in...

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus

DoD Instruction 2000.30: Global Health Engagement Activities

Policy

This instruction establishes policy, assigns responsibilities, and prescribes procedures for the conduct of global health engagement activities with partner nation (PN) entities.

Japanese Encephalitis (JE) virus is a mosquito-borne flavivirus and the most common vaccine-preventable cause of encephalitis in Asia

Policy

Individuals deploying to areas in Pacific Command (PACOM) should be administered the JE vaccine in accordance with the latest PACOM Force Health Protection Guidance.

Guidance on Medications for Prophylaxis of Malaria 13-002

Policy

This document provides guidance and best practices for the chemoprophylaxis (use of medication to prevent malaria) of Service members serving in malaria endemic regions.

<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.